Serum Institute to double COVID-19 vaccine productivity with ABEC’s bioreactors

BioPharma Reporter: The Serum Institute of India will receive six 4,000L CSR bioreactors from ABEC to help it scale up manufacture of Novavax’s COVID-19 vaccine candidate. Read the article.